Nasdaq · CIK 0001831828
VERA Vera Therapeutics, Inc.
Insider trading from SEC Form 4. Last filing 25 d ago. Close $29.88 on Oct 9, 2026, +24% from the 52-week low and -46% from the high.
Last 90 days
Net insider value
-$1.3M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
2
$1.3M by 1 insider
Insiders on file
14
with a Form 4 at this company
Price and insider trades, last year
VERAOct 9, 2026 · close 29.88
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Vera Therapeutics, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 11Weak | Marshall Fordyce PRESIDENT AND CEO sell | $685k 18,500 shares | -7% | - | |
| 10Weak | Marshall Fordyce PRESIDENT AND CEO sell | $650k 18,500 shares | -7% | - | |
| 36Weak | Patrick G Enright director buy | $250k 5,882 shares | - | +144% from low-1% from high | |
| 25Weak | Jason S Carter Chief Legal Officer sell | $107k 3,864 shares | -7% | +51% from low-43% from high | |
| 51Moderate | Patrick G Enright director buy | $5.3M 250,000 shares | +15% | +15% from low-56% from high | |
| 24Weak | Marshall Fordyce PRESIDENT AND CEO sell | $547k 19,688 shares | -9% | - | |
| 16Weak | Marshall Fordyce PRESIDENT AND CEO sell | $731k 17,500 shares | -11% | - | |
| 17Weak | Marshall Fordyce PRESIDENT AND CEO sell | $754k 17,500 shares | -20% | - | |
| 18Weak | Marshall Fordyce PRESIDENT AND CEO sell | $822k 17,500 shares | -17% | - | |
| 19Weak | Marshall Fordyce PRESIDENT AND CEO sell | $930k 19,375 shares | -21% | - | |
| 25Weak | Marshall Fordyce PRESIDENT AND CEO sell | $1.5M 30,625 shares | -31% | - | |
| 29Weak | Beth C Seidenberg director sell | $720k 15,000 shares | -10% | - | |
| 20Weak | Marshall Fordyce PRESIDENT AND CEO sell | $783k 19,375 shares | -6% | - | |
| 9Weak | Marshall Fordyce PRESIDENT AND CEO sell | $598k 15,625 shares | -5% | - |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +18,500 | $2.90 | $54k | 253,744 | 25 d ago |
| Sep 15, 2026 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -18,500 | $37.00 | $685k | 235,244 | 25 d ago |
| Sep 15, 2026 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -18,500 | $0.00 | $0 | 488,801 | 25 d ago |
| Sep 11, 2026 | Joseph R Young SVP, FINANCE, CHIEF ACCT OFFCR | MOption exercise Class A Common Stock | +5,000 | $3.94 | $20k | 80,754 | 28 d ago |
| Sep 11, 2026 | Joseph R Young SVP, FINANCE, CHIEF ACCT OFFCR | MOption exercise Stock Option (right to buy)derivative | -5,000 | $0.00 | $0 | 33,589 | 28 d ago |
| Sep 2, 2026 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +18,500 | $2.90 | $54k | 253,744 | 38 d ago |
| Sep 2, 2026 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -18,500 | $35.12 | $650k | 235,244 | 38 d ago |
| Sep 2, 2026 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -18,500 | $0.00 | $0 | 507,301 | 38 d ago |
| Dec 11, 2025 | Patrick G Enright director | POpen-market purchase Class A Common Stock | +5,882 | $42.50 | $250k | 5,882 | Dec 15, 2025 |
| Nov 21, 2025 | Jason S Carter Chief Legal Officer | SOpen-market sale Class A Common Stock | -3,864 | $27.82 | $107k | 49,136 | Nov 25, 2025 |
| Jun 23, 2025 | Patrick G Enright director | POpen-market purchase Class A Common Stockindirect: See footnote | +69,798 | $20.87 | $1.5M | 1,784,083 | Jun 25, 2025 |
| Jun 23, 2025 | Patrick G Enright director | POpen-market purchase Class A Common Stockindirect: See footnote | +139,595 | $20.87 | $2.9M | 3,569,522 | Jun 25, 2025 |
| Jun 24, 2025 | Patrick G Enright director | POpen-market purchase Class A Common Stockindirect: See footnote | +13,536 | $22.35 | $303k | 1,797,619 | Jun 25, 2025 |
| Jun 24, 2025 | Patrick G Enright director | POpen-market purchase Class A Common Stockindirect: See footnote | +27,071 | $22.35 | $605k | 3,596,593 | Jun 25, 2025 |
| May 14, 2025 | Patrick G Enright director | AGrant or award Stock Option (right to buy)derivative | +14,000 | $0.00 | $0 | 14,000 | May 16, 2025 |
| May 14, 2025 | Kimball Hall director | AGrant or award Stock Option (right to buy)derivative | +14,000 | $0.00 | $0 | 14,000 | May 16, 2025 |
| May 14, 2025 | Maha Katabi director | AGrant or award Stock Option (right to buy)derivative | +14,000 | $0.00 | $0 | 14,000 | May 16, 2025 |
| May 14, 2025 | Michael Morrissey director | AGrant or award Stock Option (right to buy)derivative | +14,000 | $0.00 | $0 | 14,000 | May 16, 2025 |
| May 14, 2025 | Scott W Morrison director | AGrant or award Stock Option (right to buy)derivative | +14,000 | $0.00 | $0 | 14,000 | May 16, 2025 |
| May 14, 2025 | Christy J. Oliger director | AGrant or award Stock Option (right to buy)derivative | +14,000 | $0.00 | $0 | 14,000 | May 16, 2025 |
| May 14, 2025 | Beth C Seidenberg director | AGrant or award Stock Option (right to buy)derivative | +14,000 | $0.00 | $0 | 14,000 | May 16, 2025 |
| May 14, 2025 | Andrew Cheng director | AGrant or award Stock Option (right to buy)derivative | +14,000 | $0.00 | $0 | 14,000 | May 16, 2025 |
| Feb 21, 2025 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -10,613 | $27.89 | $296k | 213,740 | Feb 27, 2025 |
| Feb 26, 2025 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -7,975 | $27.55 | $220k | 205,765 | Feb 27, 2025 |
| Feb 26, 2025 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -1,100 | $28.32 | $31k | 204,665 | Feb 27, 2025 |
| Feb 18, 2025 | David Lee Johnson Chief Operating Officer | AGrant or award Class A Common Stock | +26,900 | $0.00 | $0 | 26,900 | Feb 20, 2025 |
| Feb 18, 2025 | Robert Brenner Chief Medical Officer | AGrant or award Class A Common Stock | +26,900 | $0.00 | $0 | 27,474 | Feb 20, 2025 |
| Feb 18, 2025 | Marshall Fordyce PRESIDENT AND CEO | AGrant or award Class A Common Stock | +80,750 | $0.00 | $0 | 224,353 | Feb 20, 2025 |
| Feb 18, 2025 | Sean Grant CHIEF FINANCIAL OFFICER | AGrant or award Class A Common Stock | +26,900 | $0.00 | $0 | 93,237 | Feb 20, 2025 |
| Feb 18, 2025 | David Lee Johnson Chief Operating Officer | AGrant or award Stock Option (right to buy)derivative | +53,800 | $0.00 | $0 | 53,800 | Feb 20, 2025 |
| Feb 18, 2025 | Robert Brenner Chief Medical Officer | AGrant or award Stock Option (right to buy)derivative | +53,800 | $0.00 | $0 | 53,800 | Feb 20, 2025 |
| Feb 18, 2025 | Marshall Fordyce PRESIDENT AND CEO | AGrant or award Stock Option (right to buy)derivative | +161,500 | $0.00 | $0 | 161,500 | Feb 20, 2025 |
| Feb 18, 2025 | Sean Grant CHIEF FINANCIAL OFFICER | AGrant or award Stock Option (right to buy)derivative | +53,800 | $0.00 | $0 | 53,800 | Feb 20, 2025 |
| Jan 8, 2025 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +9,975 | $2.90 | $29k | 153,578 | Jan 10, 2025 |
| Jan 8, 2025 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -9,975 | $41.53 | $414k | 143,603 | Jan 10, 2025 |
| Jan 8, 2025 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +5,650 | $2.90 | $16k | 149,253 | Jan 10, 2025 |
| Jan 8, 2025 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -5,650 | $42.03 | $237k | 143,603 | Jan 10, 2025 |
| Jan 8, 2025 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +1,875 | $2.90 | $5,432 | 145,478 | Jan 10, 2025 |
| Jan 8, 2025 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -1,875 | $42.00 | $79k | 143,603 | Jan 10, 2025 |
| Jan 8, 2025 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -15,625 | $0.00 | $0 | 610,926 | Jan 10, 2025 |
| Jan 8, 2025 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,875 | $0.00 | $0 | 609,051 | Jan 10, 2025 |
| Dec 18, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +3,772 | $2.90 | $11k | 89,714 | Dec 20, 2024 |
| Dec 18, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -3,772 | $41.33 | $156k | 85,942 | Dec 20, 2024 |
| Dec 18, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +2,195 | $2.90 | $6,358 | 88,137 | Dec 20, 2024 |
| Dec 18, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -2,195 | $42.35 | $93k | 85,942 | Dec 20, 2024 |
| Dec 18, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +5,023 | $2.90 | $15k | 90,965 | Dec 20, 2024 |
| Dec 18, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -5,023 | $43.52 | $219k | 85,942 | Dec 20, 2024 |
| Dec 18, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +4,635 | $2.90 | $13k | 90,577 | Dec 20, 2024 |
| Dec 18, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -4,635 | $44.03 | $204k | 85,942 | Dec 20, 2024 |
| Dec 18, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +1,875 | $2.90 | $5,432 | 87,817 | Dec 20, 2024 |
| Dec 18, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -1,875 | $43.81 | $82k | 85,942 | Dec 20, 2024 |
| Dec 19, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +57,661 | $2.90 | $167k | 143,603 | Dec 20, 2024 |
| Dec 18, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -15,625 | $0.00 | $0 | 686,087 | Dec 20, 2024 |
| Dec 18, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,875 | $0.00 | $0 | 684,212 | Dec 20, 2024 |
| Dec 19, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -57,661 | $0.00 | $0 | 626,551 | Dec 20, 2024 |
| Dec 11, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +14,925 | $2.90 | $43k | 100,867 | Dec 13, 2024 |
| Dec 11, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -14,925 | $46.91 | $700k | 85,942 | Dec 13, 2024 |
| Dec 11, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +700 | $2.90 | $2,028 | 86,642 | Dec 13, 2024 |
| Dec 11, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -700 | $47.55 | $33k | 85,942 | Dec 13, 2024 |
| Dec 11, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +1,775 | $2.90 | $5,142 | 87,717 | Dec 13, 2024 |
| Dec 11, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -1,775 | $46.94 | $83k | 85,942 | Dec 13, 2024 |
| Dec 11, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +100 | $2.90 | $290 | 86,042 | Dec 13, 2024 |
| Dec 11, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -100 | $47.65 | $4,765 | 85,942 | Dec 13, 2024 |
| Dec 11, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -15,625 | $0.00 | $0 | 703,587 | Dec 13, 2024 |
| Dec 11, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,875 | $0.00 | $0 | 701,712 | Dec 13, 2024 |
| Nov 25, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +6,579 | $2.90 | $19k | 92,521 | Nov 27, 2024 |
| Nov 25, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -6,579 | $47.05 | $310k | 85,942 | Nov 27, 2024 |
| Nov 25, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +7,665 | $2.90 | $22k | 93,607 | Nov 27, 2024 |
| Nov 25, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -7,665 | $48.18 | $369k | 85,942 | Nov 27, 2024 |
| Nov 25, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +1,381 | $2.90 | $4,000 | 87,323 | Nov 27, 2024 |
| Nov 25, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -1,381 | $48.80 | $67k | 85,942 | Nov 27, 2024 |
| Nov 25, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +1,875 | $2.90 | $5,432 | 87,817 | Nov 27, 2024 |
| Nov 25, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -1,875 | $48.76 | $91k | 85,942 | Nov 27, 2024 |
| Nov 25, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +1,875 | $2.90 | $5,432 | 87,817 | Nov 27, 2024 |
| Nov 25, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -1,875 | $49.00 | $92k | 85,942 | Nov 27, 2024 |
| Nov 25, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -15,625 | $0.00 | $0 | 722,962 | Nov 27, 2024 |
| Nov 25, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,875 | $0.00 | $0 | 721,087 | Nov 27, 2024 |
| Nov 25, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,875 | $0.00 | $0 | 719,212 | Nov 27, 2024 |
| Nov 18, 2024 | Jason S Carter Chief Legal Officer | AGrant or award Class A Common Stock | +53,000 | $0.00 | $0 | 53,000 | Nov 20, 2024 |
| Nov 18, 2024 | Jason S Carter Chief Legal Officer | AGrant or award Stock Option (right to buy)derivative | +108,000 | $0.00 | $0 | 108,000 | Nov 20, 2024 |
| Nov 13, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +12,218 | $2.90 | $35k | 98,160 | Nov 15, 2024 |
| Nov 13, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -12,218 | $49.54 | $605k | 85,942 | Nov 15, 2024 |
| Nov 13, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +3,307 | $2.90 | $9,580 | 89,249 | Nov 15, 2024 |
| Nov 13, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -3,307 | $50.28 | $166k | 85,942 | Nov 15, 2024 |
| Nov 13, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +100 | $2.90 | $290 | 86,042 | Nov 15, 2024 |
| Nov 13, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -100 | $51.20 | $5,120 | 85,942 | Nov 15, 2024 |
| Nov 13, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +1,565 | $2.90 | $4,533 | 87,507 | Nov 15, 2024 |
| Nov 13, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -1,565 | $49.59 | $78k | 85,942 | Nov 15, 2024 |
| Nov 13, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +310 | $2.90 | $898 | 86,252 | Nov 15, 2024 |
| Nov 13, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -310 | $50.35 | $16k | 85,942 | Nov 15, 2024 |
| Nov 13, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +1,875 | $2.90 | $5,432 | 87,817 | Nov 15, 2024 |
| Nov 13, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -1,875 | $49.57 | $93k | 85,942 | Nov 15, 2024 |
| Nov 13, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +1,875 | $2.90 | $5,432 | 87,817 | Nov 15, 2024 |
| Nov 13, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -1,875 | $49.52 | $93k | 85,942 | Nov 15, 2024 |
| Nov 13, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +1,875 | $2.90 | $5,432 | 87,817 | Nov 15, 2024 |
| Nov 13, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -1,875 | $49.50 | $93k | 85,942 | Nov 15, 2024 |
| Nov 13, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Class A Common Stock10b5-1 | +7,500 | $2.90 | $22k | 93,442 | Nov 15, 2024 |
| Nov 13, 2024 | Marshall Fordyce PRESIDENT AND CEO | SOpen-market sale Class A Common Stock10b5-1 | -7,500 | $49.00 | $368k | 85,942 | Nov 15, 2024 |
| Nov 13, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -15,625 | $0.00 | $0 | 753,587 | Nov 15, 2024 |
| Nov 13, 2024 | Marshall Fordyce PRESIDENT AND CEO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,875 | $0.00 | $0 | 751,712 | Nov 15, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Robert BrennerChief Medical Officer
- Jason S CarterChief Legal Officer
- Andrew Chengceo, president, officer, director
- Patrick G Enrightdirector
- Marshall FordycePRESIDENT AND CEO
- Sean GrantCHIEF FINANCIAL OFFICER
- Kimball Halldirector
- David Lee JohnsonChief Operating Officer
- Maha Katabidirector
- Michael Morrisseyceo, president, officer, director
- Scott W Morrisondirector
- Christy J. Oligerdirector
- Beth C Seidenbergdirector, owner
- Joseph R YoungSVP, FINANCE, CHIEF ACCT OFFCR
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.